Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210031474 210013658 1.53 60.4 Palliative (P) null 2016-09-02 DACTINOMYCIN + CYCLO + VINCRISTINE 2 N 210042069 PACLITAXEL
210031475 210022533 1.57 66 Palliative (P) 2017-07-15 2017-07-16 Cyclophosphamide High Dose 02 N 210042072 ICE
210031476 210013662 1.67 64.6 null 2018-04-23 2018-05-02 Capecitabine (14 day) + Irinotecan N N 210042107 IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE
210031477 210013663 1.77 73.9 Curative (C) 2016-04-20 2016-08-02 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE Y N 210042133 BR14 TRIAL
210031478 210013666 1.65 null null null 2018-02-15 Ofatumumab Weekly N null 210042147 PACKER MAINTENANCE
210031479 210013672 null 0 Curative (C) 2017-01-13 2017-01-21 Cytarabine Intrathecal (any age) null null 210042169 CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE
210031480 210013673 null 52.6 Curative (C) 2017-12-27 2018-09-19 RCEOP null null 210000284 BEVACIZUMAB + NIVOLUMAB
210031481 210013676 1.75 7.1 Curative (C) 2017-02-05 2018-09-25 TRASTUZUMAB N N 210001193 BEVACIZUMAB + NIVOLUMAB
210031482 210013678 1.73 68.5 Disease modification (D) 2017-08-02 2017-11-25 TRASTUZUMAB N null 210001293 IRINOTECAN + TEMOZOLOMIDE
210031483 210013679 1.9 69.8 Disease modification (D) null 2019-06-02 Bortezomib + CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB 02 N 210004103 IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE
210031484 210013684 1.68 32.5 Disease modification (D) 2019-05-30 2019-05-30 Bevacizumab + Irinotecan N N 210008519 CARBOPLATIN + PROCARBAZINE
210031485 210013685 null 102 Disease modification (D) 2017-05-16 2017-05-17 Cytarabine intrathecal N N 210008669 CYCLO + FLUDARABINE + RITUXIMAB
210031486 210013687 1.76 92.4 Palliative (P) 2018-01-28 2018-02-13 Cyclophosphamide High Dose 2 null 210008796 RCEOP
210031487 210013691 1.57 0 Adjuvant (A) 2017-07-21 2017-09-29 PACLITAXEL Y N 210010386 CYCLO + FLUDARABINE + RITUXIMAB
210031488 210013693 1.82 82.1 Curative (C) 2015-04-08 2017-11-02 CLL210 TRIAL 2 N 210011848 CYCLOPHOSPHAMIDE HIGH DOSE
210031489 210013696 null null null 2019-03-04 2019-03-26 IDARUBICIN 99 Y 210012655 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
210031490 210013698 1.62 null Palliative (P) 2017-03-12 2017-03-14 Fludarabine IV Y N 210014040 MYELOMA XI TRIAL
210031491 210028153 1.75 null null 2019-01-07 2019-02-10 Paclitaxel (2 or 3 weekly) 02 N 210014521 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
210031492 210013702 null 117.5 Palliative (P) null 2018-07-28 Maintenance Therapy ALL Y N 210018519 CARBOPLATIN + ETOPOSIDE + VINCRISTINE
210031493 210013707 1.83 66.8 Palliative (P) 2019-08-29 2019-09-19 CYTARABINE + FLUDARABINE + IDARUBICIN 02 Y 210021249 DAUNORUBICIN + VNCRISTINE
210031494 210022562 1.65 73.55 Palliative (P) 2018-03-15 2018-11-25 CETUXIMAB + IRINOTECAN Y N 210021270 ALL MAINTENANCE
210031495 210013709 1.78 96.1 Curative (C) 2018-07-29 2018-08-04 CNS Medbl Std Risk Maint Cisplatin N null 210021324 CYTARABINE + RITUXIMAB
210031496 210013712 1.83 null null 2018-11-14 2018-11-14 Bevacizumab + Irinotecan N N 210021726 FLAG
210031497 210013713 null 54 null 2018-02-17 2018-02-18 Hydroxycarbamide null null 210021743 FLUDARABINE
210031498 210013718 1.54 54.4 Palliative (P) 2017-07-31 2017-07-31 IVE-R 02 N 210021911 ALL MAINTENANCE
210031499 210013720 null 58.4 Palliative (P) 2013-11-18 2016-05-06 Azacitidine N N 210022095 CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE
210031500 210013723 1.79 68.6 Curative (C) 2019-01-31 2019-02-07 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE 2 N 210022560 UKALL2003
210031501 210013725 1.7 70.2 Palliative (P) 2015-10-23 2015-11-12 Alemtuzumab + Cyclophos TBI Allo 2 N 210022634 CLARITY TRIAL
210031502 210013730 0 75.2 Palliative (P) 2017-05-18 2017-05-31 CARBOPLATIN + LOMUSTINE + VINCRISTINE N N 210023716 CYTARABINE + ETOPOSIDE
210031503 210022581 0 null Curative (C) 2015-08-26 2015-09-23 ICE-R 2 N 210024647 DARATUMUMAB
210031504 210013745 1.56 82 Palliative (P) 2019-06-17 2019-07-03 BR14 TRIAL N N 210024837 ALL MAINTENANCE
210031505 210022584 null 61 null null 2018-09-12 Alemtuzumab+Busulfan+CyclophosphMUD null null 210025000 ICE-R
210031506 210013747 0 null 5 2017-10-27 2017-11-07 BR14 TRIAL N N 210025077 CYTARABINE
210031507 210013750 null 74 Palliative (P) 2016-09-20 2016-10-04 DARATUMUMAB 02 N 210025389 IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE
210031508 210022590 1.64 87.4 Curative (C) 2016-12-19 2017-04-13 Oxaliplatin + Modified de Gramont 2 null 210025657 CLL210 TRIAL
210031509 210013757 1.72 91.2 Curative (C) 2018-11-14 2019-01-15 TRASTUZUMAB N N 210025797 ALL INDUCTION
210031510 210028173 0 16.2 Disease modification (D) 2017-05-02 2017-05-28 ALEMTUZUMAB + ETOPOSIDE 02 N 210025907 MYELOMA XI TRIAL
210031511 210033700 null 86.4 Disease modification (D) null 2017-01-08 IMMUNOGLOBULIN null null 210025962 ALEMTUZUMAB + ETOPOSIDE
210031512 210033701 1.78 60.8 Curative (C) 2018-02-10 2018-05-08 Cyclophosphamide High Dose N N 210026674 ALL
210031513 210013763 1.57 64.1 Neo-adjuvant (N) 2013-12-28 2014-03-18 DOXORUBICIN N N 210026763 RUXOLITINIB
210031514 210013767 1.73 12.7 Curative (C) 2018-03-17 2018-03-18 Brentuximab null null 210027544 PACLITAXEL
210031515 210013768 1.83 16.3 null 2015-01-28 2016-03-14 Depocyte Intrathecal N null 210027549 ICE
210031516 210013769 1.63 61.8 Curative (C) 2014-07-23 2014-09-09 Intensification 1 2 3(ALL) (Mtx) 1 N 210027566 CLARITY TRIAL
210031517 210013773 0 86.4 Disease modification (D) 2019-04-04 2019-04-04 BR14 TRIAL N N 210027899 CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE
210031518 210013781 1.6 57 Curative (C) 2019-05-14 2019-05-19 Cytarabine HD + Methotrexate HD N N 210028000 R-EPOCH
210031519 210013781 null 70.4 Palliative (P) null 2014-10-23 Azacitidine Y null 210028000 CYTARABINE INTRATHECAL
210031520 210013785 1.6 60.6 Curative (C) 2017-10-04 2017-12-12 PACLITAXEL N null 210028634 CVD
210031521 210031567 null 60.4 Curative (C) 2019-02-25 2019-06-11 Alemtuzumab+Busulfan+CyclophosphMUD N N 210029239 RCEOP
210031522 210022615 1.54 82.3 Curative (C) 2019-03-01 2019-04-05 Cladribine + Rituximab 2 N 210029261 IVAC
210031523 210013802 1.77 98 Disease modification (D) 2016-08-07 2017-02-11 CVAD 02 N 210029535 CYCLOPHOSPHAMIDE HIGH DOSE